Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal antibody targeting interleukin-15

EU orphan designation number: EU/3/16/1681   
Active ingredient: Humanised monoclonal antibody targeting interleukin-15
Indication: Treatment of eosinophilic oesophagitis
Sponsor: Calypso Biotech B.V.
Toyo Ito Tower, Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2016 Orphan designation EMA/OD/004/16 (2016)4122 of 27/06/2016
21/12/2017 Transfer of orphan designation EMA/OD/004/16/T/01 (2017)9000 of 18/12/2017